Comparative evaluation of potential components for group B meningococcal vaccine by passive protection in the infant rat and in vitro bactericidal assay
- 1 August 1989
- Vol. 7 (4) , 325-328
- https://doi.org/10.1016/0264-410x(89)90194-1
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Experimental meningococcal meningitis in the infant ratMicrobial Pathogenesis, 1988
- Neisseria meningitidis group B serosubtyping using monoclonal antibodies in whole-cell ElisaMicrobial Pathogenesis, 1988
- Protective efficacy of monoclonal antibodies to class 1 and class 3 outer membrane proteins of Neisseria meningitidis B:15:P1.16 in infant rat infection model: new prospects for vaccine developmentMicrobial Pathogenesis, 1987
- Prospects for the prevention of meningococcal disease: special reference to group BVaccine, 1987
- MENINGOCOCCAL SEROTYPES AND SEROGROUP B DISEASE IN NORTH-WEST EUROPEThe Lancet, 1986
- Safety and antigenicity studies of a polyvalent meningococcal protein-polysaccharide vaccineAntonie van Leeuwenhoek, 1986
- Serotype Antigens of Neisseria meningitidis and a Proposed Scbemefor Designation of SerotypesClinical Infectious Diseases, 1985
- Meningococcal Disease: Still with UsClinical Infectious Diseases, 1983
- Problems in the definition of meningococcal serotypesFEMS Microbiology Letters, 1982
- Immunologic Response of Man to Group B Meningococcal Polysaccharide VaccinesThe Journal of Infectious Diseases, 1972